ClinConnect ClinConnect Logo
Search / Trial NCT04934358

Motivational Interventions and Physical Exercise in Patients With Fragility Fracture

Launched by MAIMÓNIDES BIOMEDICAL RESEARCH INSTITUTE OF CÓRDOBA · Jun 14, 2021

Trial Information

Current as of August 25, 2025

Recruiting

Keywords

Fragility Fracture Physical Exercise Motivational Intervention

ClinConnect Summary

This clinical trial is studying how motivational support and a physical exercise program can help patients who have suffered a fragility fracture, such as a hip fracture. Fragility fractures occur from minor falls or injuries and can lead to a higher risk of future fractures and difficulties with daily activities. The goal of the trial is to see if a tailored approach to exercise, along with motivation, can improve patients' ability to perform everyday tasks, encourage them to stay active, and ultimately reduce hospital visits and the risk of further fractures.

To be eligible for this trial, participants need to be over 50 years old and have recently experienced a hip fracture due to a low-energy fall, which has been surgically repaired. They should have been somewhat independent before the fracture, meaning they could manage most daily activities on their own. Participants can expect to engage in a personalized rehabilitation program that focuses on their individual exercise capacity, which is designed to help them recover more effectively. This trial is currently recruiting participants, and being part of it could significantly contribute to improving their quality of life and reducing the risk of future fractures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Present a hip fracture (includes cervical fracture and trochanteric), classified in the 10th version of the International Classification of Diseases (ICD-10-ES) with codes S72-S72.26X;
  • In addition, the fracture must be due to fragility: fracture due to a low-energy trauma or not proportional to the consequences (Hermoso de Mendoza, 2003);
  • To have received a surgical repair by replacement arthroplasty or internal fixation (ICD-10-ES procedures: 0SU and 0SR) in a period of less than one week;
  • To be recovering in a trauma and orthopedic unit and/or be transferred to a rehabilitation unit or discharged;
  • Before the fracture, independent or mild dependence for activities of daily living (Barthel index\> 60) and living at home;
  • To have the cognitive ability to give informed consent (ANNEX I);
  • To live and be domiciled in a basic health area covered by the study hospital complex
  • To be over 50 years of age
  • Exclusion Criteria:
  • Presence of low cognitive level (scores below 23 points in Lobo's Mini-cognitive exam);
  • Patients with pathological fractures due to skeletal alterations other than osteoporosis;
  • Presence of more than one fall (other than the cause of hospital admission) in the last year;
  • Presence of uncorrected anemia (hemoglobin concentration \<9/dL), acute infectious disease (C-reactive protein\> 10 mg / L), severe cardiorespiratory disease (for example: unstable angina; severe heart failure identified by the New York Heart Association as class III-IV), musculoskeletal or neurological diseases (for example, major amputation of lower limbs) that make physical exercise impossible.

About Maimónides Biomedical Research Institute Of Córdoba

The Maimónides Biomedical Research Institute of Córdoba is a leading research organization dedicated to advancing biomedical science through innovative clinical trials and translational research. Located in Córdoba, Spain, the institute focuses on a multidisciplinary approach to address pressing health challenges, fostering collaboration among researchers, clinicians, and industry partners. Its commitment to excellence in research is complemented by state-of-the-art facilities and a robust ethical framework, ensuring the highest standards of scientific integrity and patient safety. By prioritizing cutting-edge research and the development of novel therapeutic strategies, the Maimónides Biomedical Research Institute aims to contribute significantly to the improvement of global health outcomes.

Locations

Córdoba, Cordoba, Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials